Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2019-04-26 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
2019年第一季度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (367 characters) stating that the company's 2019 first quarter report will be published on a specific date and website. It does not contain the actual financial data or report itself, but only informs investors about the upcoming release. According to the 'MENU VS MEAL' rule, such a brief notice about report publication is classified as a Report Publication Announcement (RPA).
2019-04-26 Chinese
2019年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 First Quarter Report" of 福安药业（集团）股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as income, profit, cash flow, balance sheet items, shareholder information, and management discussion on financial performance and risks. The length is substantial (15,000 characters), and it includes actual financial statements and analysis, not just an announcement or summary. The content matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data and analysis. Therefore, the document should be classified as an Interim / Quarterly Report (IR). Q1 2019
2019-04-26 Chinese
上海东方华银律师事务所关于公司2018年年度股东大会之法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from Shanghai Dongfang Huayin Law Firm regarding the 2018 Annual General Meeting (AGM) of Fu'an Pharmaceutical (Group) Co., Ltd. It details the procedures for convening and holding the AGM, the qualifications of attendees, the voting procedures, and the results of various resolutions passed at the AGM. The document does not contain the actual annual report, audit report, or financial statements but rather confirms the legality and validity of the AGM process and resolutions. It is a legal opinion related to the AGM, not the AGM materials themselves or the voting results announcement. Given the content focuses on the AGM and is a legal opinion letter, the most appropriate classification is AGM Information (AGM-R). The document length is about 5377 characters, which is sufficient for a detailed legal opinion rather than a brief announcement. Therefore, the classification is AGM-R with high confidence.
2019-04-26 Chinese
2018年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the Annual General Meeting (AGM) of 福安药业 (Fuan Pharmaceutical) for the year 2018. It details the voting results on various agenda items including the 2018 annual reports, audit reports, financial statements, profit distribution, and appointment of auditors. The document includes voting percentages, attendance details, and legal opinions on the meeting's validity. It does not contain the full annual report or financial statements themselves but rather the official announcement of the AGM decisions and voting outcomes. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 4620 characters, which is consistent with a detailed voting results announcement rather than the full report or presentation. Therefore, the correct classification is DVA with high confidence.
2019-04-26 Chinese
关于股票交易异常波动的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company 福安药业股份有限公司 regarding abnormal stock price fluctuations over several trading days. It includes explanations about the situation, confirmation of no undisclosed material information, risk warnings related to a cooperation intention agreement, and reminders to investors about information disclosure compliance. The document does not contain financial statements, detailed financial performance data, or management discussion of results. It is a regulatory disclosure about stock trading behavior and related risks, typical of a Regulatory Filings (RNS) category. The document length is 2535 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication that this is an earnings release, annual report, or other specific financial report type. Therefore, the appropriate classification is Regulatory Filings (RNS).
2019-04-17 Chinese
关于控股股东部分股份质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder. It details the number of shares pledged, the pledgee, and the percentage of shares involved. There is no financial report, earnings data, or management discussion. The content fits the category of a regulatory announcement about share pledging, which is typically classified under Regulatory Filings (RNS). The document length is short and it is an announcement rather than a report or detailed financial statement.
2019-04-16 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.